Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
LUPIN
LUPIN
2,124.50+41.5 (+1.99%)
21 Sep, 12:00 AM

Stock Scores

Quality Score

99.7 / 100

Value Score

61.0 / 100

Price Momentum Score

55.6 / 100

QVM Score

91.6 / 100

Key Metrics

Market Cap
97146.20
P/E (TTM)
18.22
P/B
4.33
P/S (TTM)
3.47
EV/EBITDA
11.35
CAPE (5Y)
51.63
ROE (TTM)
26.90
ROCE (TTM)
27.69
ROA (TTM)
15.78
Avg 3Y ROE
20.68
Earnings 3Y CAGR
131.28
Sales 3Y CAGR
18.88
Sales 5Y CAGR
13.02
Debt/Equity
0.29
Consensus TP
2505.00
Strong Buy %
11.43
Promoter Holding
46.85
Pledged %
0.00

Share Price

Track Lupin Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

2,124.5041.5 (1.99%)
3.34% in past 1 year
1 Week returns: 1.41 %
Low
2,033.5
High
2,144.7
1 Month returns: -3.51 %
Low
2,033.5
High
2,237.9
1 Year returns: 3.34 %
Low
1,900.0
High
2,530.0
3 Year CAGR: 23.52 %
Low
1,091.5
High
2,530.0
5 Year CAGR: 17.96 %
Low
583.0
High
2,530.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Lupin Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 17.86 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -45.83%

What is P/E Ratio?

Median: 32.97
Value 17.86
-0.87741.89
High and improving ROE

The company reported strong ROE of 26.9% for 12-month ended 30 Jun 2026 and ROE improved by 605 bps from 1 year ago

What is ROE (FY)?

High and improving operating margin

The company reported strong operating margin of 25.69% for 12-month ended 30 Jun 2026 and operating margin improved by 692 bps from 1 year ago

What is Operating profit margin?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 23.12% for 12-month ended 30 Jun 2026 and the growth was 12.44 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.68
Value 23.12
-99.6111701.8
Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 62.43% for 12-month ended 30 Jun 2026 and the growth was 55.23 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.29 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.03 in the last 1 year

What is Debt to Equity?

Company's earnings are of high quality

Earnings quality score of 76.0 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

76.0 / 100

Consistently pays dividend

The company has not missed dividend payments once in the last 10 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative
Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -2.57% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

98.64Apr 26101.33May 26101.54Jun 26101.74Jul 2699.17Aug 2699.42Sep 26
Low dividend yield

The company has a low dividend yield of 0.58%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
No red flags found!
No significant red flags found in the stock.

Financial Snapshot

See detailed analysis

Multi-year trends for Lupin Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
010k20k30k16.6 K CrMar 202320.0 K CrMar 202422.7 K CrMar 202528.0 K CrMar 2026
Profit After Tax FY
02k4k6k430.1 CrMar 20231.9 K CrMar 20243.3 K CrMar 20255.3 K CrMar 2026
ROE FY
0%10%20%30%3.5%Mar 202314.3%Mar 202420.8%Mar 202526.9%Mar 2026
EBITDA FY
05k10k1.8 K CrMar 20233.8 K CrMar 20245.3 K CrMar 20258.4 K CrMar 2026

Lupin Ltd. Shareholding Pattern

Quarterly breakdown of Lupin Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Promoter
46.92
46.92
46.91
46.88
46.86
46.84
46.83
46.81
46.78
47.10
47.11
47.10
47.08
47.07
47.06
47.04
47.01
46.98
46.96
46.95
46.92
46.90
46.90
46.89
46.86
46.85
Indian Promoter
46.64
46.64
46.62
46.59
46.58
46.55
46.54
46.53
46.50
46.82
46.83
46.82
46.80
46.79
46.77
46.76
46.73
46.70
46.68
46.67
46.64
46.62
46.62
46.61
46.57
46.57
Foreign Promoter
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
Institutions
39.23
40.17
40.50
40.34
40.46
40.69
40.41
40.39
41.85
41.45
41.44
43.36
42.52
43.30
44.42
45.84
46.05
46.10
46.60
46.79
46.88
46.81
47.06
47.07
47.03
47.07
Mutual Funds / UTI
10.14
11.94
12.58
13.21
13.05
11.43
13.33
13.26
15.72
15.86
16.44
16.47
16.96
17.00
16.71
18.92
16.82
16.23
16.89
16.92
17.55
19.35
20.57
18.01
16.93
14.84
FI/Bank/Insurance
5.94
6.56
7.17
7.75
9.03
10.25
11.04
11.50
11.12
10.96
11.10
11.53
11.87
11.98
12.40
9.84
10.02
9.56
7.24
6.41
6.34
4.64
4.48
5.59
6.12
6.98
Govt
0.28
0.29
0.29
0.29
0.29
0.28
0.28
0.28
0.29
0.29
0.00
-
-
-
-
0.01
0.01
0.01
0.01
0.01
0.01
-
-
-
-
-
FII
22.68
21.31
20.35
18.97
17.87
18.60
15.66
15.28
14.65
14.27
13.81
13.98
13.32
13.93
14.99
16.11
18.29
19.32
21.50
22.04
21.46
21.25
20.50
21.50
21.70
22.42
Other Institutions
0.19
0.08
0.11
0.11
0.21
0.13
0.09
0.07
0.07
0.07
0.09
1.39
0.37
0.38
0.31
0.96
0.92
0.98
0.97
1.40
1.52
1.56
1.50
1.98
2.27
2.83
Non-Institution
13.85
12.91
12.60
12.79
12.69
12.47
12.76
12.79
11.37
11.45
11.45
9.53
10.40
9.64
8.52
7.11
6.93
6.92
6.44
6.26
6.20
6.28
6.06
6.03
6.11
6.08
Bodies Corporate
0.71
0.77
0.59
0.52
0.50
0.46
0.52
0.76
0.74
0.83
0.73
0.72
0.55
0.44
0.41
0.40
0.39
0.31
0.32
0.30
0.30
0.28
0.24
0.24
0.26
0.34
Others (incl. Retail)
No. of shareholders
13.14
2,89,803
12.14
2,76,365
12.01
2,72,037
12.27
2,97,697
12.19
2,91,875
12.01
3,00,326
12.24
3,59,277
12.03
3,59,979
10.63
3,76,699
10.62
3,80,987
10.72
3,76,199
8.81
3,58,915
9.85
3,46,431
9.20
3,20,997
8.11
2,87,413
6.71
2,79,810
6.54
2,78,410
6.61
2,86,746
6.12
2,77,269
5.96
2,79,907
5.90
2,81,132
6.00
2,84,551
5.82
2,78,295
5.79
2,86,959
5.85
2,88,330
5.74
2,98,124

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence
#IndexWeightRank
1SHI: Biotech13.36%4 / 15
2Nifty Pharma5.25%7 / 20
3Nifty Healthcare4.57%9 / 20
4Nifty Alpha Low Vol 303.24%17 / 30
5Nifty Midcap 502.24%17 / 50
6Nifty Midcap 150 Momentum 502.21%15 / 50
7Nifty Midcap 1001.52%18 / 100
8Nifty Midcap 1501.25%18 / 149
9NIFTY Large Midcap 2500.63%35 / 250
10Nifty 5000.27%81 / 499

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Lupin Ltd. shares as reported to NSE and BSE.

NameMonthTransactionHolding % pre transactionAverage priceQty.Transaction value
Dr. Kamal K Sharma
Designated Person
September-2021
Market Sale (Disposal)
9th Sep 2021
0.04 %₹ 985.0015.00 k₹ 1.48 cr
Nilesh D. Gupta
Promoter
August-2021
Market Purchase (Acquisition)
27th Aug 2021
0.20 %₹ 943.585.30 k₹ 50.01 lac
Sunil Makharia
Designated Person
August-2021
Market Sale (Disposal)
18th Aug 2021
0.00 %₹ 974.0020.00 k₹ 1.95 cr
Ramesh Swaminathan
Designated Person
August-2021
Market Sale (Disposal)
16th Aug 2021
0.00 %₹ 978.0010.00 k₹ 97.80 lac
Mr. Sunil Makharia
Designated Person
June-2021
Market Sale (Disposal)
30th Jun 2021
0.01 %₹ 1,161.002.00 k₹ 23.22 lac
Mr. Naresh Gupta
Designated Person
June-2021
Market Sale (Disposal)
30th Jun 2021
0.01 %₹ 1,163.053.00 k₹ 34.89 lac
Mr. Debabrata Chakravorty
Designated Person
June-2021
Market Sale (Disposal)
30th Jun 2021
0.00 %₹ 1,158.303.00 k₹ 34.75 lac
Ms. Minaxi Bhatt
Designated Person
June-2021
Market Sale (Disposal)
24th Jun 2021
0.00 %₹ 1,126.651.00 k₹ 11.27 lac
Mr. Jon Stelzmiller
Designated Person
June-2021
Market Sale (Disposal)
23rd Jun 2021
0.00 %₹ 1,123.131.23 k₹ 13.76 lac
Mr. Naresh Gupta
Designated Person
June-2021
Market Sale (Disposal)
23rd Jun 2021
0.01 %₹ 1,150.15500.00₹ 5.75 lac
…

Corporate Actions

History of Lupin Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Dividend₹ 18/share
    Record date: 17th Jul 2026Ex-date: 17th Jul 2026
    Announced on: 7th May 2026
  2. Dividend₹ 12/share
    Record date: 25th Jul 2025Ex-date: 25th Jul 2025
    Announced on: 15th May 2025
  3. Dividend₹ 8/share
    Record date: 16th Jul 2024Ex-date: 16th Jul 2024
    Announced on: 6th May 2024
  4. Dividend₹ 4/share
    Record date: 14th Jul 2023Ex-date: 14th Jul 2023
    Announced on: 4th Jul 2023
  5. Dividend₹ 4/share
    Record date: 15th Jul 2022Ex-date: 14th Jul 2022
    Announced on: 18th May 2022

Company Profile

Overview of Lupin Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Lupin Limited is a pharmaceutical company, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. It operates in India and the United States...
Key personnel
Mr. Amit Kumar Gupta
Compliance Officer, Company Secretary
Dr. Thierry Volle
President - EMEA and Emerging Markets
Mr. Christoph Funke
Chief Technical Operations Officer
Dr. Shahin Fesharaki
Chief Scientific Officer
Mr. Amit Kumar Gupta
Compliance Officer, Company Secretary
Dr. Ranjana Pathak
Chief Quality Officer
Mrs. Manju Deshbandhu GuptaD
Non-Executive Chairman of the Board
Ms. Vinita D. GuptaD
Chief Executive Officer, Executive Director
View all
Incorporated on
01 Mar 1983
Last Annual
31 Mar 2026
Last Interim
30 Jun 2026
No. of Employees
24,939
IPO date
30 Nov 1994
Free Float
24,22,50,987
Phone no.
+912266402323
Address
3rd Floor, Kalpataru Inspire,, Off. Western Expressway Highway,, Santacruz (East),, MUMBAI, 400055, India

Frequently Asked Questions

What is the current share price of Lupin Ltd.?
The current share price of Lupin Ltd. is ₹ 2,124.50 as of 21 Sep 2026.
What is the market capitalisation of Lupin Ltd.?
The market capitalisation of Lupin Ltd. stands at ₹ 97,146.20 Cr.
What is the PE ratio of Lupin Ltd.?
The Price-to-Earnings (PE) ratio of Lupin Ltd. is 18.22 as of the latest trailing twelve months data.
What is the ROE and ROCE of Lupin Ltd.?
Lupin Ltd. has a Return on Equity (ROE) of 26.90% and a Return on Capital Employed (ROCE) of 27.69% as per the latest financial reports.
What is the 52-week high and low of Lupin Ltd.?
The 52-week high of Lupin Ltd. is - and the 52-week low is -.
What is the dividend yield of Lupin Ltd.?
The dividend yield of Lupin Ltd. is 0.56% based on the current market price.
What is the FII and DII holding in Lupin Ltd.?
Foreign Institutional Investors (FII) hold 22.42%, Domestic Institutional Investors (DII) hold 21.82% and retail/public investors hold 5.74% of Lupin Ltd. shares.
What sector does Lupin Ltd. belong to?
Lupin Ltd. operates in the Healthcare sector. 40% of analysts have a Buy or Strong Buy rating on Lupin Ltd. with a consensus target price of ₹ 2,505.00, implying 17.91% upside from current levels.
What is the beta of Lupin Ltd.?
The beta of Lupin Ltd. is 0.52, indicating its price volatility relative to the broader market. Over the past 1 year, Lupin Ltd. has delivered an absolute return of 3.99%.
What is the RSI of Lupin Ltd.?
The 14-day Relative Strength Index (RSI) of Lupin Ltd. is 44.07, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.